Hudson Valley Investment Advisors Inc. ADV boosted its position in Danaher Co. (NYSE:DHR) by 3.8% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 30,040 shares of the conglomerate’s stock after purchasing an additional 1,108 shares during the quarter. Hudson Valley Investment Advisors Inc. ADV’s holdings in Danaher were worth $4,339,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of DHR. Barings LLC grew its holdings in Danaher by 8.7% in the 2nd quarter. Barings LLC now owns 11,922 shares of the conglomerate’s stock valued at $1,703,000 after buying an additional 952 shares in the last quarter. Capital Advisors Ltd. LLC grew its holdings in shares of Danaher by 527.5% during the 2nd quarter. Capital Advisors Ltd. LLC now owns 320 shares of the conglomerate’s stock worth $46,000 after purchasing an additional 269 shares during the period. Sullivan Bruyette Speros & Blaney LLC grew its holdings in shares of Danaher by 5.2% during the 2nd quarter. Sullivan Bruyette Speros & Blaney LLC now owns 14,598 shares of the conglomerate’s stock worth $2,086,000 after purchasing an additional 717 shares during the period. Lenox Wealth Advisors LLC grew its holdings in shares of Danaher by 231.3% during the 2nd quarter. Lenox Wealth Advisors LLC now owns 1,302 shares of the conglomerate’s stock worth $186,000 after purchasing an additional 909 shares during the period. Finally, Asahi Life Asset Management CO. LTD. purchased a new position in shares of Danaher during the 2nd quarter worth $177,000. 78.44% of the stock is owned by hedge funds and other institutional investors.
Shares of Danaher stock opened at $138.01 on Friday. The business has a 50-day moving average of $141.25 and a 200 day moving average of $137.63. Danaher Co. has a 12 month low of $94.59 and a 12 month high of $147.33. The stock has a market capitalization of $98.83 billion, a price-to-earnings ratio of 30.53, a price-to-earnings-growth ratio of 2.30 and a beta of 0.94. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.32 and a quick ratio of 1.91.
The company also recently announced a quarterly dividend, which will be paid on Friday, October 25th. Investors of record on Friday, September 27th will be issued a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a yield of 0.49%. The ex-dividend date of this dividend is Thursday, September 26th. Danaher’s dividend payout ratio (DPR) is 15.04%.
A number of equities analysts have recently weighed in on the company. Credit Suisse Group reiterated an “outperform” rating and set a $151.00 price target on shares of Danaher in a report on Monday, October 14th. Robert W. Baird increased their price target on Danaher from $131.00 to $148.00 and gave the stock an “outperform” rating in a report on Friday, July 19th. Wolfe Research set a $157.00 price target on Danaher and gave the stock a “buy” rating in a report on Thursday, September 26th. Royal Bank of Canada set a $134.00 price target on Danaher and gave the stock a “hold” rating in a report on Friday, July 19th. Finally, ValuEngine cut Danaher from a “buy” rating to a “hold” rating in a report on Wednesday, October 2nd. Four research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. Danaher has a consensus rating of “Buy” and an average price target of $146.29.
In other news, Chairman Mitchell P. Rales bought 2,500 shares of the stock in a transaction that occurred on Friday, August 23rd. The stock was bought at an average cost of $139.52 per share, for a total transaction of $348,800.00. Following the acquisition, the chairman now directly owns 3,030,453 shares of the company’s stock, valued at approximately $422,808,802.56. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Brian W. Ellis sold 1,010 shares of the firm’s stock in a transaction dated Friday, July 26th. The shares were sold at an average price of $144.04, for a total value of $145,480.40. Following the transaction, the insider now owns 20,889 shares of the company’s stock, valued at $3,008,851.56. The disclosure for this sale can be found here. Insiders have sold a total of 38,279 shares of company stock valued at $5,461,569 over the last 90 days. 11.40% of the stock is currently owned by company insiders.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
Read More: Federal Reserve
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.